Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
LENZ Therapeutics, Inc. | LENZ | 257.46K | $1.46M |
Trevi Therapeutics, Inc. | TRVI | 260K | $4.85M |
Agilon Health, Inc. | AGL | 262.6K | $28.15M |
EyePoint Pharmaceuticals, Inc. | EYPT | 268.52K | $3.84M |
iRhythm Technologies, Inc. | IRTC | 269.65K | $32.07M |
Tarsus Pharmaceuticals, Inc. | TARS | 277.09K | $17.44M |
DexCom, Inc. | DXCM | 343K | $23.1M |
Alphatec Holdings, Inc. | ATEC | 360K | $3.11M |
Insmed Incorporated | INSM | 362.15K | $38.61M |
Janux Therapeutics, Inc. | JANX | 367.01K | $5.64M |
Omada Health | OMDA | 373K | $8.19M |
Ocular Therapeutix, Inc. | OCUL | 383.72K | $3.77M |
Azenta, Inc. | AZTA | 403K | $10.28M |
Vera Therapeutics, Inc. | VERA | 427.58K | $18.35M |
Kymera Therapeutics, Inc. | KYMR | 453.16K | $51.96M |
Tango Therapeutics, Inc. | TNGX | 456.55K | $14.27M |
Enliven Therapeutics, Inc. | ELVN | 464.63K | $23.58M |
Altimmune, Inc. | ALT | 471.46K | $1.43M |
Mineralys Therapeutics, Inc. | MLYS | 484.95K | $13.08M |
Caris Life Sciences, Inc. | CAI | 487.5K | $8.69M |